Detalhe da pesquisa
1.
Comparison of infection-induced and vaccine-induced immunity against COVID-19 in patients with cirrhosis.
Hepatology
; 77(1): 186-196, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35712794
2.
Ursodeoxycholic acid is associated with a reduction in SARS-CoV-2 infection and reduced severity of COVID-19 in patients with cirrhosis.
J Intern Med
; 293(5): 636-647, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37018129
3.
Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosis.
J Hepatol
; 77(5): 1349-1358, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36181987
4.
COVID-19 vaccine effectiveness and community prevalence of Alpha, Delta and Omicron variants in patients with cirrhosis.
Gut
; 72(9): 1800-1802, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36562753
5.
Viral Vector Vaccines Are Victorious Against COVID-19 in Patients with Cirrhosis.
Dig Dis Sci
; 68(2): 349-351, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35947303
6.
Hepatocellular Carcinoma in Primary Biliary Cholangitis.
Clin Liver Dis
; 26(4): 691-704, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36270724